Business Description
Brawn Biotech Ltd
ISIN : INE899B01015
Total Employee Number:
9Compare
Compare
Traded in other countries / regions
530207.India IPO Date
2000-09-18Description
Brawn Biotech Ltd is a healthcare company. It is engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.21 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.14 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.1 | |||||
3-Year FCF Growth Rate | -26.3 | |||||
3-Year Book Growth Rate | -11.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.73 | |||||
9-Day RSI | 41.09 | |||||
14-Day RSI | 43.85 | |||||
3-1 Month Momentum % | 2.54 | |||||
6-1 Month Momentum % | 10.34 | |||||
12-1 Month Momentum % | 17.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.47 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 261.04 | |||||
Days Sales Outstanding | 99.58 | |||||
Days Payable | 340.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 14.48 | |||||
Operating Margin % | -2.64 | |||||
Net Margin % | 5.54 | |||||
EBITDA Margin % | 0.75 | |||||
FCF Margin % | 0.5 | |||||
OCF Margin % | 0.66 | |||||
ROE % | 24.74 | |||||
ROA % | 4.44 | |||||
ROIC % | -6.94 | |||||
3-Year ROIIC % | 1.69 | |||||
ROC (Joel Greenblatt) % | 0.15 | |||||
ROCE % | 0.08 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.19 | |||||
PE Ratio without NRI | 6.19 | |||||
Shiller PE Ratio | 20.46 | |||||
Price-to-Owner-Earnings | 6.34 | |||||
PS Ratio | 0.34 | |||||
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 1.4 | |||||
Price-to-Free-Cash-Flow | 68.04 | |||||
Price-to-Operating-Cash-Flow | 52.08 | |||||
EV-to-EBIT | 1066.2 | |||||
EV-to-EBITDA | 45.99 | |||||
EV-to-Revenue | 0.35 | |||||
EV-to-FCF | 65.07 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Projected-FCF | 1.75 | |||||
Price-to-Median-PS-Value | 1.17 | |||||
Price-to-Graham-Number | 0.62 | |||||
| Price-to-Net-Current-Asset-Value | 10.05 | |||||
Earnings Yield (Greenblatt) % | 0.1 | |||||
FCF Yield % | 1.41 | |||||
Forward Rate of Return (Yacktman) % | 9.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Brawn Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 169.778 | ||
| EPS (TTM) (₹) | 3.26 | ||
| Beta | -0.361 | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.27 | ||
| Volatility % | 28.07 | ||
| 14-Day RSI | 43.85 | ||
| 14-Day ATR (₹) | 0.711933 | ||
| 20-Day SMA (₹) | 21.499 | ||
| 12-1 Month Momentum % | 17.43 | ||
| 52-Week Range (₹) | 16.66 - 24.37 | ||
| Shares Outstanding (Mil) | 3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brawn Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brawn Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Brawn Biotech Ltd Frequently Asked Questions
What is Brawn Biotech Ltd(BOM:530207)'s stock price today?
The current price of BOM:530207 is ₹20.21. The 52 week high of BOM:530207 is ₹24.37 and 52 week low is ₹16.66.
When is next earnings date of Brawn Biotech Ltd(BOM:530207)?
The next earnings date of Brawn Biotech Ltd(BOM:530207) is .
Does Brawn Biotech Ltd(BOM:530207) pay dividends? If so, how much?
Brawn Biotech Ltd(BOM:530207) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Brawn Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers